Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2004 | 1 |
2007 | 1 |
2008 | 1 |
2011 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Association of serum cytokine levels with treatment response to pegylated interferon and ribavirin therapy in genotype 1 chronic hepatitis C patients.
J Infect Dis. 2011 Apr 15;203(8):1087-95. doi: 10.1093/infdis/jiq165. Epub 2011 Mar 11.
J Infect Dis. 2011.
PMID: 21398397
Free article.
Anti-Helicobacter pylori seropositivity: influence on severity and treatment response in patients with chronic hepatitis C.
Umemura T, Muto H, Tanaka E, Matsumoto A, Ichijo T, Yoshizawa K, Akamatsu T, Kiyosawa K; Nagano Interferon Treatment Research Group.
Umemura T, et al.
J Viral Hepat. 2007 Jan;14(1):48-54. doi: 10.1111/j.1365-2893.2006.00770.x.
J Viral Hepat. 2007.
PMID: 17212644
Free article.
Clinical Trial.
Item in Clipboard
Serum chemokine levels are associated with the outcome of pegylated interferon and ribavirin therapy in patients with chronic hepatitis C.
Yoneda S, Umemura T, Joshita S, Ichijo T, Matsumoto A, Yoshizawa K, Katsuyama Y, Ota M, Tanaka E; Nagano Interferon Treatment Research Group.
Yoneda S, et al.
Hepatol Res. 2011 Jun;41(6):587-93. doi: 10.1111/j.1872-034X.2011.00802.x. Epub 2011 Apr 19.
Hepatol Res. 2011.
PMID: 21504519
Item in Clipboard
Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors.
Shirakawa H, Matsumoto A, Joshita S, Komatsu M, Tanaka N, Umemura T, Ichijo T, Yoshizawa K, Kiyosawa K, Tanaka E; Nagano Interferon Treatment Research Group.
Shirakawa H, et al.
Hepatology. 2008 Dec;48(6):1753-60. doi: 10.1002/hep.22543.
Hepatology. 2008.
PMID: 18925643
Item in Clipboard
Types of human leukocyte antigen and decrease in HCV core antigen in serum for predicting efficacy of interferon-Alpha in patients with chronic hepatitis C: analysis by a prospective study.
Muto H, Tanaka E, Matsumoto A, Yoshizawa K, Kiyosawa K; Nagano Interferon Treatment Research Group.
Muto H, et al.
J Gastroenterol. 2004 Jul;39(7):674-80. doi: 10.1007/s00535-003-1364-8.
J Gastroenterol. 2004.
PMID: 15293139
Item in Clipboard
Cite
Cite